Silencing TRIM29 Sensitizes Non-small Cell Lung Cancer Cells to Anlotinib by Promoting Apoptosis via Binding RAD50
CONCLUSION: Finally, we concluded that the increased sensitivity to anlotinib in NSCLC/AR cells was achieved by knocking down TRIM29, besides, the positive effects of TRIM29 knockdown were attributed to the promotion of apoptosis via binding to RAD50 in NSCLC/AR cell nucleus. Therefore, TRIM29 might become a potential target for overcoming anlotinib resistance in NSCLC treatment.PMID:37644752 | DOI:10.2174/1568009623666230829143148
Source: Current Cancer Drug Targets - Category: Cancer & Oncology Authors: Min Wu Meng-Meng Jin Xiao-Hui Cao Lei Zhao Yong-Huai Li Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Gastroschisis Repair | Genetics | Lung Cancer | Men | Non-Small Cell Lung Cancer | Study